Skip to content
Disclosery

Benchmark Capital Advisors: PHYS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Benchmark Capital Advisors on PHYS, newest first. How the timeline and the estimate are built.

Benchmark Capital Advisors held 263,221 PHYS shares at 2018-12-31 per its 13F-HR filed 2019-02-11.

the latest 13F is the newest step

  1. period ended2018-12-31
    13F 263,221 shares
    Change vs previous 13F +5,850 shares

    2.71% of the 13F portfolio, value $2,714,000.

    13F-HR 0001352859-19-000002 filed by Benchmark Capital Advisors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2018-09-30
    13F 257,371 shares
    Change vs previous 13F -6,000 shares

    1.85% of the 13F portfolio, value $2,458,000.

    13F-HR 0001352859-18-000009 filed by Benchmark Capital Advisors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2018-06-30
    13F 263,371 shares
    Change vs previous 13F -13,100 shares

    2.03% of the 13F portfolio, value $2,681,000.

    13F-HR 0001352859-18-000007 filed by Benchmark Capital Advisors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2018-03-31
    13F 276,471 shares
    Change vs previous 13F -7,200 shares

    2.36% of the 13F portfolio, value $2,972,000.

    13F-HR 0001352859-18-000005 filed by Benchmark Capital Advisors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2017-12-31
    13F 283,671 shares
    Change vs previous 13F -1,000 shares

    2.35% of the 13F portfolio, value $3,004,000.

    13F-HR 0001352859-18-000002 filed by Benchmark Capital Advisors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2017-09-30
    13F 284,671 shares
    Change vs previous 13F +20,300 shares

    2.32% of the 13F portfolio, value $2,972,000.

    13F-HR 0001352859-17-000011 filed by Benchmark Capital Advisors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2017-06-30
    13F 264,371 shares
    Change vs previous 13F -1,700 shares

    2.12% of the 13F portfolio, value $2,678,000.

    13F-HR 0001352859-17-000009 filed by Benchmark Capital Advisors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2017-03-31
    13F 266,071 shares
    Change vs previous 13F not available

    2.16% of the 13F portfolio, value $2,719,000.

    13F-HR 0001352859-17-000007 filed by Benchmark Capital Advisors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).